Piper Sandler Reiterates Overweight on Glaukos, Raises Price Target to $240

Benzinga · 10/29 13:44
Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $195 to $240.